Everolimus provides some benefit for people with papillary renal cell cancer
A study published in the European Journal of Cancer shows that [...]
VEGF/mTOR combination for non-clear cell kidney cancer
The combination of vascular endothelial growth factor (VEGF)-directed and mammalian [...]
Sunitinib vs everolimus for advanced non-clear cell kidney cancer
In a recent study published in the journal Lancet Oncology, [...]
